NatCure Sciences, Inc.
NatCure, a private start-up company, seeks funding for drug development of a plant-derived compound for autoimmune disease treatment
NatCure Sciences is a biopharmaceutical discovery company developing drug products isolated from plant extracts with history in traditional medicine from Africa and China. The lead product NAT-100 is being developed to treat Inflammatory Bowel Disease (IBD) and Multiple Sclerosis (MS). The active NAT-100 compound is water soluble with anti-inflammatory and immunosuppressive activity with little or no known-toxicity in man.